Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK III: Low-Dose Ketamine for Mucositis in Children
NCT00224692Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in mucositis, sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2003; status: terminated.
02
Drugs
ketamine
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT00224692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224692.